Reference
Othman T, et al. A Comprehensive Cancer Center Experience with Hyper-CVAD Plus Ponatinib As Frontline Therapy for Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Blood 138 (Suppl. 1): abstr. 4394, 23 Nov 2021. Available from: URL: http://doi.org/10.1182/blood-2021-149276 [abstract]
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1888, 48 (2022). https://doi.org/10.1007/s40278-022-08390-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-08390-4